Literature DB >> 17034346

Proteasomal dysfunction: a common feature of neurodegenerative diseases? Implications for the environmental origins of neurodegeneration.

B Halliwell1.   

Abstract

The neurodegenerative diseases that afflict humans affect different part of the nervous system and have different symptoms and prognoses, yet they have certain things in common. One of them is defects in the clearance of abnormal or other "unwanted" proteins, particularly affecting the proteasome system. In this review, I advance two concepts: (a) that defects in protein clearance can be a fundamental cause of neurodegeneration, and (b) that because proteasome inhibitors are widespread in nature, their ingestion may contribute to "spontaneous" neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034346     DOI: 10.1089/ars.2006.8.2007

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  10 in total

Review 1.  Intersection of nuclear receptors and the proteasome on the epigenetic landscape.

Authors:  H Karimi Kinyamu; Wendy N Jefferson; Trevor K Archer
Journal:  Environ Mol Mutagen       Date:  2008-01       Impact factor: 3.216

Review 2.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

3.  Glutamine deamidation: differentiation of glutamic acid and gamma-glutamic acid in peptides by electron capture dissociation.

Authors:  Xiaojuan Li; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2010-05-01       Impact factor: 6.986

4.  Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine.

Authors:  April A Dukes; Victor S Van Laar; Michael Cascio; Teresa G Hastings
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

5.  Aging-from molecules to populations.

Authors:  Miriam Sander; Kirsten Avlund; Martin Lauritzen; Tina Gottlieb; Barry Halliwell; Tinna Stevnsner; Ulla Wewer; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2008-08-23       Impact factor: 5.432

Review 6.  Dopamine and aging: intersecting facets.

Authors:  C David Rollo
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

Review 7.  The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease.

Authors:  Marcus J Calkins; Delinda A Johnson; Jessica A Townsend; Marcelo R Vargas; James A Dowell; Tracy P Williamson; Andrew D Kraft; Jong-Min Lee; Jiang Li; Jeffrey A Johnson
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

Review 8.  Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates.

Authors:  Marianna A Maretina; Galina Y Zheleznyakova; Kristina M Lanko; Anna A Egorova; Vladislav S Baranov; Anton V Kiselev
Journal:  Curr Genomics       Date:  2018-08       Impact factor: 2.236

Review 9.  Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules.

Authors:  Chiara Lanzillotta; Fabio Di Domenico
Journal:  Biomolecules       Date:  2021-02-11

10.  Effects of Anthocyanins on CAG Repeat Instability and Behaviour in Huntington's Disease R6/1 Mice.

Authors:  Linda Møllersen; Olve Moldestad; Alexander D Rowe; Anja Bjølgerud; Ingunn Holm; Linda Tveterås; Arne Klungland; Lars Retterstøl
Journal:  PLoS Curr       Date:  2016-07-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.